Not bashing, just being realistic. The point is, if they were doing all 5 implants nearly simultaneously, the failure of one would not halt trials, barring a catastrophe. Let's say though that 3 of 5 would be succesful. That's still a great improvement from current nonexistent treatments and reason to continue development.
However, if the first implant is one of the two unsuccessful ones of five, it's possible that would effectively end all trials.
News 
Market Data 
Discover 
AI
